| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.023 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
-0.021 |
0.9 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |